Schizophrenia and bipolar disorder: The road from similarities and clinical heterogeneity to neurobiological types
- PMID: 25704299
- DOI: 10.1016/j.cca.2015.02.029
Schizophrenia and bipolar disorder: The road from similarities and clinical heterogeneity to neurobiological types
Abstract
Although diagnosis is a central issue in medical care, in psychiatry its value is still controversial. The function of diagnosis is to indicate treatments and to help clinicians take better care of patients. The fundamental role of diagnosis is to predict outcome and prognosis. To date serious concern persists regarding the clinical utility and predictive validity of the diagnosis system in psychiatry, which is at the most syndromal. Schizophrenia and bipolar disorder, which nosologists consider two distinct disorders, are the most discussed psychiatric illnesses. Recent findings in different fields of psychiatric research, such as neuroimaging, neuropathology, neuroimmunology, neuropsychology and genetics, have led to other conceptualizations. Individuals with schizophrenia or bipolar disorder vary greatly with regard to symptoms, illness course, treatment response, cognitive and functional impairment and biological correlates. In fact, it is possible to find heterogeneous correlates even within the same syndrome, i.e., from one stage of the disorder to another. Thus, it is possible to identify different subsyndromes, which share some clinical and neurobiological characteristics. The main goal of modern psychiatry is to ovethrow these barriers and to obtain a better understanding of the biological profiles underlying heterogeneous clinical features and thus reduce the variance and lead to a homogeneous definition. The translational research model, which connects the basic neuroscience research field with clinical experience in psychiatry, aims to investigate different neurobiological features of syndromes and of the shared neurobiological features between two syndromes. In fact, this approach should help us to better understand the neurobiological pathways underlying clinical entities, and even to distinguish different, more homogeneous, diagnostic subtypes.
Keywords: Biomarker; Bipolar disorder; Diagnosis; Diagnostic subtypes; Schizophrenia.
Copyright © 2015 Elsevier B.V. All rights reserved.
Similar articles
-
Schizophrenia and bipolar disorder: differences and overlaps.Curr Opin Psychiatry. 2006 Mar;19(2):165-70. doi: 10.1097/01.yco.0000214342.52249.82. Curr Opin Psychiatry. 2006. PMID: 16612197 Review.
-
[How to differentiate schizophrenia from bipolar disorder using cognitive assessment?].Encephale. 2009 Apr;35(2):139-45. doi: 10.1016/j.encep.2008.03.011. Epub 2008 Sep 23. Encephale. 2009. PMID: 19393382 Review. French.
-
Cognitive impairment and functional outcome in schizophrenia and bipolar disorder.J Clin Psychiatry. 2006 Oct;67(10):e12. J Clin Psychiatry. 2006. PMID: 17107235
-
Bipolar disorder and schizophrenia: distinct illnesses or a continuum?J Clin Psychiatry. 2003;64 Suppl 6:23-7; discussion 28. J Clin Psychiatry. 2003. PMID: 12720477 Review.
-
Fear of harm, a possible phenotype of pediatric bipolar disorder: a dimensional approach to diagnosis for genotyping psychiatric syndromes.J Affect Disord. 2009 Nov;118(1-3):28-38. doi: 10.1016/j.jad.2009.06.016. Epub 2009 Jul 23. J Affect Disord. 2009. PMID: 19631388
Cited by
-
The microbiome, immunity, and schizophrenia and bipolar disorder.Brain Behav Immun. 2017 May;62:46-52. doi: 10.1016/j.bbi.2016.12.010. Epub 2016 Dec 18. Brain Behav Immun. 2017. PMID: 28003152 Free PMC article. Review.
-
Alteration of gray matter microstructure in schizophrenia.Brain Imaging Behav. 2018 Feb;12(1):54-63. doi: 10.1007/s11682-016-9666-7. Brain Imaging Behav. 2018. PMID: 28102528 Free PMC article.
-
Exploring biomarkers and transcriptional factors in type 2 diabetes by comprehensive bioinformatics analysis on RNA-Seq and scRNA-Seq data.Ann Transl Med. 2022 Sep;10(18):1017. doi: 10.21037/atm-22-4303. Ann Transl Med. 2022. PMID: 36267740 Free PMC article.
-
Gut microbiome: An intermediary to neurotoxicity.Neurotoxicology. 2019 Dec;75:41-69. doi: 10.1016/j.neuro.2019.08.005. Epub 2019 Aug 24. Neurotoxicology. 2019. PMID: 31454513 Free PMC article. Review.
-
Comparative serum proteomic analysis of a selected protein panel in individuals with schizophrenia and bipolar disorder and the impact of genetic risk burden on serum proteomic profiles.Transl Psychiatry. 2022 Nov 9;12(1):471. doi: 10.1038/s41398-022-02228-x. Transl Psychiatry. 2022. PMID: 36351892 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical